Executive record
Charles F. Wagner, Jr.
Charles F. Wagner, Jr. is in the CFO seat at Vertex Pharmaceuticals Incorporated until a disclosed change takes effect (effective January 1, 2027).
2 verified records · 1 company · current seat on the record: Vertex Pharmaceuticals Incorporated
Career line from the records
2Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.
2026-09-01TransitionVertex Pharmaceuticals Incorporatedcurrent seat
Vertex Pharmaceuticals Incorporated CFO transition: Jonathan Poole to succeed Charles F. Wagner, Jr.Named as the outgoing officer
effective January 1, 2027 · 8-K filed September 1, 2026 · sec.gov, Item 5.02
2026-02-1310-K signatureVertex Pharmaceuticalscurrent seat
Signed the annual report as Executive Vice President and Chief Operating & Financial Officer (Principal Financial Officer)
10-K filed February 13, 2026 · sec.gov
Companies
1This page lists only verified filing records that name Charles F. Wagner, Jr., matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.